FDA Import Refusal SCS-9927209-3/10003/1 — NOVO NORDISK
The FDA refused shipment SCS-9927209-3/10003/1 from NOVO NORDISK (Canada) on Jan 12, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 12, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,75